Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2005

01-09-2005 | Review

Primary and secondary autoimmune neutropenia

Authors: Franco Capsoni, Piercarlo Sarzi-Puttini, Alberto Zanella

Published in: Arthritis Research & Therapy | Issue 5/2005

Login to get access

Abstract

Antineutrophil antibodies are well recognized causes of neutropenia, producing both quantitative and qualitative defects in neutrophils and increased risk for infection. In primary autoimmune neutropenia (AIN) of infancy, a moderate to severe neutropenia is the sole abnormality; it is rarely associated with serious infections and exhibits a self-limited course. Chronic idiopathic neutropenia of adults is characterized by occurrence in late childhood or adulthood, greater prevalence among females than among males, and rare spontaneous remission. Secondary AIN is more commonly seen in adults and underlying causes include collagen disorders, drugs, viruses and lymphoproliferative disorders. In most patients with AIN, antibodies recognize antigens located on the IgG Fc receptor type 3b but other target antigens have been recently identified in secondary AIN. Granulocyte colony-stimulating factor is a proven treatment in patients with AIN of all types and is now preferred to other possible therapies.
Literature
1.
go back to reference Boxer LA, Greenberg MS, Boxer GJ, Stossel TP: Autoimmune neutropenia. N Engl J Med. 1975, 293: 748-753.CrossRefPubMed Boxer LA, Greenberg MS, Boxer GJ, Stossel TP: Autoimmune neutropenia. N Engl J Med. 1975, 293: 748-753.CrossRefPubMed
2.
go back to reference Lalezari P, Jiang AF, Yegen L, Santorineou M: Chronic autoimmune neutropenia due to anti-NA2 antibody. N Engl J Med. 1975, 293: 744-747.CrossRefPubMed Lalezari P, Jiang AF, Yegen L, Santorineou M: Chronic autoimmune neutropenia due to anti-NA2 antibody. N Engl J Med. 1975, 293: 744-747.CrossRefPubMed
3.
go back to reference Lawrence JS, Craddock CG, Campbell TN: Antineutrophil serum, its use in studies of white cell dynamics. J Lab Clin Med. 1967, 69: 88-101.PubMed Lawrence JS, Craddock CG, Campbell TN: Antineutrophil serum, its use in studies of white cell dynamics. J Lab Clin Med. 1967, 69: 88-101.PubMed
4.
go back to reference Simpson DM, Ross R: Effects of heterologous anti-neutrophil serum in guinea pigs. Hematologic and ultrastructural observations. Am J Pathol. 1971, 65: 79-102.PubMedCentralPubMed Simpson DM, Ross R: Effects of heterologous anti-neutrophil serum in guinea pigs. Hematologic and ultrastructural observations. Am J Pathol. 1971, 65: 79-102.PubMedCentralPubMed
5.
go back to reference Hadley AG, Holburn AM, Bunch C, Chapel H: Antigranulocyte opsonic activity and autoimmune neutropenia. Br J Haematol. 1986, 63: 581-589.CrossRefPubMed Hadley AG, Holburn AM, Bunch C, Chapel H: Antigranulocyte opsonic activity and autoimmune neutropenia. Br J Haematol. 1986, 63: 581-589.CrossRefPubMed
6.
go back to reference Hadley AG, Byran MA, Chapel H, Bunch C, Holburn AM: Antigranulocyte opsonic activity in sera from patients with systemic lupus erythematosus. Br J Haematol. 1987, 65: 61-65.CrossRefPubMed Hadley AG, Byran MA, Chapel H, Bunch C, Holburn AM: Antigranulocyte opsonic activity in sera from patients with systemic lupus erythematosus. Br J Haematol. 1987, 65: 61-65.CrossRefPubMed
7.
8.
go back to reference Harmon DC, Weitzman SA, Stossel TP: The severity of immune neutropenia correlates with the maturational specificity of antineutrophil antibodies. Br J Haematol. 1984, 58: 209-215.CrossRefPubMed Harmon DC, Weitzman SA, Stossel TP: The severity of immune neutropenia correlates with the maturational specificity of antineutrophil antibodies. Br J Haematol. 1984, 58: 209-215.CrossRefPubMed
9.
go back to reference Maheshwari A, Christensen RD, Calhoun DA: Immune-mediated neutropenia in the neonate. Acta Pediatr. 2002, 438: 98-103. 10.1080/080352502320764265.CrossRef Maheshwari A, Christensen RD, Calhoun DA: Immune-mediated neutropenia in the neonate. Acta Pediatr. 2002, 438: 98-103. 10.1080/080352502320764265.CrossRef
10.
go back to reference Shastri KA, Logue GL: Autoimmune neutropenia. Blood. 1993, 81: 1984-1995.PubMed Shastri KA, Logue GL: Autoimmune neutropenia. Blood. 1993, 81: 1984-1995.PubMed
11.
go back to reference Bux J, Chapman J: Report on the second international granulocyte serology workshop. Transfusion. 1997, 37: 977-10.1046/j.1537-2995.1997.37997454028.x.CrossRefPubMed Bux J, Chapman J: Report on the second international granulocyte serology workshop. Transfusion. 1997, 37: 977-10.1046/j.1537-2995.1997.37997454028.x.CrossRefPubMed
12.
go back to reference Bux J, Kober B, Kiefel V, Mueller-Eckhardt C: Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal-antibody-specific immobilization of granulocyte antigen. Transfusion Med. 1993, 3: 157-162.CrossRef Bux J, Kober B, Kiefel V, Mueller-Eckhardt C: Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal-antibody-specific immobilization of granulocyte antigen. Transfusion Med. 1993, 3: 157-162.CrossRef
13.
go back to reference Bux J, Behrens G, Jaeger G, Welte K: Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood. 1998, 91: 181-186.PubMed Bux J, Behrens G, Jaeger G, Welte K: Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood. 1998, 91: 181-186.PubMed
14.
go back to reference Bux J: Nomenclature of granulocyte alloantigens. Transfusion. 1999, 39: 662-663. 10.1046/j.1537-2995.1999.39060662.x.CrossRefPubMed Bux J: Nomenclature of granulocyte alloantigens. Transfusion. 1999, 39: 662-663. 10.1046/j.1537-2995.1999.39060662.x.CrossRefPubMed
15.
go back to reference Lucas GF, Metcalfe P: Platelet and granulocyte glycoprotein polymorphisms. Transfusion Med. 2000, 10: 157-174. 10.1046/j.1365-3148.2000.00250.x.CrossRef Lucas GF, Metcalfe P: Platelet and granulocyte glycoprotein polymorphisms. Transfusion Med. 2000, 10: 157-174. 10.1046/j.1365-3148.2000.00250.x.CrossRef
16.
go back to reference Bruin MCA, von dem Borne AEGK, Tamminga RYJ, Kleijer M, Buddelmeijer L, de Haas M: Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood. 1999, 94: 1797-1802.PubMed Bruin MCA, von dem Borne AEGK, Tamminga RYJ, Kleijer M, Buddelmeijer L, de Haas M: Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood. 1999, 94: 1797-1802.PubMed
17.
go back to reference Hartman KR, Wright DG: Identification of autoantibodies specific for the neutrophil adhesion glycoprotein CD11b/CD18 in patients with autoimmune neutropenia. Blood. 1991, 15: 1096-1104. Hartman KR, Wright DG: Identification of autoantibodies specific for the neutrophil adhesion glycoprotein CD11b/CD18 in patients with autoimmune neutropenia. Blood. 1991, 15: 1096-1104.
18.
go back to reference Kramer N, Perez HD, Goldstein IM: An immunoglobulin inhibitorof polymorphonuclear leukocyte motility in a patient with recurrent infection. N Engl J Med. 1980, 303: 1253-1258.CrossRefPubMed Kramer N, Perez HD, Goldstein IM: An immunoglobulin inhibitorof polymorphonuclear leukocyte motility in a patient with recurrent infection. N Engl J Med. 1980, 303: 1253-1258.CrossRefPubMed
19.
go back to reference Logue GL, Shastri KA, Laughlin M, Shimm DS, Ziolkowski LM, Iglehart JL: Idiopathic neutropenia: antineutrophil antibodies and clinical correlations. Am J Med. 1991, 90: 211-216.CrossRefPubMed Logue GL, Shastri KA, Laughlin M, Shimm DS, Ziolkowski LM, Iglehart JL: Idiopathic neutropenia: antineutrophil antibodies and clinical correlations. Am J Med. 1991, 90: 211-216.CrossRefPubMed
20.
go back to reference Smith MA, Smith JG: The use of colony-stimulating factor for treatment of autoimmune neutropenia. Curr Opin Hematol. 2001, 8: 165-169. 10.1097/00062752-200105000-00007.CrossRefPubMed Smith MA, Smith JG: The use of colony-stimulating factor for treatment of autoimmune neutropenia. Curr Opin Hematol. 2001, 8: 165-169. 10.1097/00062752-200105000-00007.CrossRefPubMed
21.
go back to reference Killick SB, Marsh JC, Hale G, Waldmann H, Kelly SJ, Gordon-Smith EC: Sustained remission of severe resisitant autoimmune neutropenia with Campath-1H. Br J Haematol. 1997, 97: 306-308. 10.1046/j.1365-2141.1997.612718.x.CrossRefPubMed Killick SB, Marsh JC, Hale G, Waldmann H, Kelly SJ, Gordon-Smith EC: Sustained remission of severe resisitant autoimmune neutropenia with Campath-1H. Br J Haematol. 1997, 97: 306-308. 10.1046/j.1365-2141.1997.612718.x.CrossRefPubMed
22.
go back to reference Marsh JC, Gordon-Smith EC: CAMPATH-1H in the treatment of autoimmune cytopenias. Cytotherapy. 2001, 3: 189-195. 10.1080/146532401753174133.CrossRefPubMed Marsh JC, Gordon-Smith EC: CAMPATH-1H in the treatment of autoimmune cytopenias. Cytotherapy. 2001, 3: 189-195. 10.1080/146532401753174133.CrossRefPubMed
23.
go back to reference Bux J, Robertz-Vaupel GM, Glasmacher A, Dengler HJ, Mueller-Eckhardt C: Autoimmune neutropenia due to NA1 specific antibodies in primary biliary cirrhosis. Br J Haematol. 1991, 77: 121-122.CrossRefPubMed Bux J, Robertz-Vaupel GM, Glasmacher A, Dengler HJ, Mueller-Eckhardt C: Autoimmune neutropenia due to NA1 specific antibodies in primary biliary cirrhosis. Br J Haematol. 1991, 77: 121-122.CrossRefPubMed
24.
go back to reference Yamato E, Fujioka Y, Masugi F, Nakamaru M, Tahara Y, Kurata Y, Ogihara T: Autoimmune neutropenia with anti-neutrophil autoantibody associated with Sjogren's syndrome. Am J Med Sci. 1990, 300: 102-103.CrossRefPubMed Yamato E, Fujioka Y, Masugi F, Nakamaru M, Tahara Y, Kurata Y, Ogihara T: Autoimmune neutropenia with anti-neutrophil autoantibody associated with Sjogren's syndrome. Am J Med Sci. 1990, 300: 102-103.CrossRefPubMed
26.
go back to reference Starkebaum G, Price TH, Lee MY, Arend WP: Autoimmune neutropenia in systemic lupus erythematosus. Arthritis Rheum. 1978, 21: 504-512.CrossRefPubMed Starkebaum G, Price TH, Lee MY, Arend WP: Autoimmune neutropenia in systemic lupus erythematosus. Arthritis Rheum. 1978, 21: 504-512.CrossRefPubMed
27.
go back to reference Starkebaum G, Arend WP, Nardella FA, Gavin SE: Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome. J Lab Clin Med. 1980, 96: 238-251.PubMed Starkebaum G, Arend WP, Nardella FA, Gavin SE: Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome. J Lab Clin Med. 1980, 96: 238-251.PubMed
28.
go back to reference Gupta V, Eden AJ, Mills MJ: Helicobacter pylori and autoimmune neutropenia. Clin Lab Haematol. 2002, 24: 183-185. 10.1046/j.1365-2257.2002.00441.x.CrossRefPubMed Gupta V, Eden AJ, Mills MJ: Helicobacter pylori and autoimmune neutropenia. Clin Lab Haematol. 2002, 24: 183-185. 10.1046/j.1365-2257.2002.00441.x.CrossRefPubMed
29.
go back to reference Ribera E, Ocana I, Almirante B, Gomez J, Monreal P, Martinez Vazquez JM: Autoimmune neutropenia and thrombocytopenia associated with development of antibodies to human immunodeficiency virus. J Infect. 1989, 18: 167-170. 10.1016/S0163-4453(89)91206-1.CrossRefPubMed Ribera E, Ocana I, Almirante B, Gomez J, Monreal P, Martinez Vazquez JM: Autoimmune neutropenia and thrombocytopenia associated with development of antibodies to human immunodeficiency virus. J Infect. 1989, 18: 167-170. 10.1016/S0163-4453(89)91206-1.CrossRefPubMed
30.
go back to reference Lehmann HW, von Landenberg P, Modrow S: Parvovirus B19 infection and autoimmune disease. Autoimmun Rev. 2003, 2: 218-223. 10.1016/S1568-9972(03)00014-4.CrossRefPubMed Lehmann HW, von Landenberg P, Modrow S: Parvovirus B19 infection and autoimmune disease. Autoimmun Rev. 2003, 2: 218-223. 10.1016/S1568-9972(03)00014-4.CrossRefPubMed
31.
go back to reference Trebo MM, Thorner PS, Weitzman S: Wilms tumor and autoimmune neutropenia. Med Pediatr Oncol. 2000, 34: 299-300. 10.1002/(SICI)1096-911X(200004)34:4<299::AID-MPO21>3.0.CO;2-J.CrossRefPubMed Trebo MM, Thorner PS, Weitzman S: Wilms tumor and autoimmune neutropenia. Med Pediatr Oncol. 2000, 34: 299-300. 10.1002/(SICI)1096-911X(200004)34:4<299::AID-MPO21>3.0.CO;2-J.CrossRefPubMed
32.
33.
go back to reference Kozuka T, Kojima K, Kaneda K, Takenaka K, Manabe Y, Hirata Y, Okuma S, Toki H, Tanimoto M: Autoimmune neutropenia associated with multiple sclerosis. Intern Med. 2003, 42: 102-104.CrossRefPubMed Kozuka T, Kojima K, Kaneda K, Takenaka K, Manabe Y, Hirata Y, Okuma S, Toki H, Tanimoto M: Autoimmune neutropenia associated with multiple sclerosis. Intern Med. 2003, 42: 102-104.CrossRefPubMed
34.
go back to reference Klumpp TR, Herman JH, Macdonald JS, Schnell MK, Mullaney M, Mangan KF: Autoimmune neutropenia following peripheral blood stem cell transplantation. Am J Hematol. 1992, 41: 215-217.CrossRefPubMed Klumpp TR, Herman JH, Macdonald JS, Schnell MK, Mullaney M, Mangan KF: Autoimmune neutropenia following peripheral blood stem cell transplantation. Am J Hematol. 1992, 41: 215-217.CrossRefPubMed
35.
go back to reference Tosi P, Bandini G, Tazzari P, Raspadori D, Cirio TM, Rosti G, Bonini A, Conte R, Tura S: Autoimmune neutropenia after unrelated bone marrow transplantation. Bone Marrow Transplant. 1994, 14: 1003-1004.PubMed Tosi P, Bandini G, Tazzari P, Raspadori D, Cirio TM, Rosti G, Bonini A, Conte R, Tura S: Autoimmune neutropenia after unrelated bone marrow transplantation. Bone Marrow Transplant. 1994, 14: 1003-1004.PubMed
36.
37.
go back to reference Jondeau G, Bierling P, Rossert J, Rondeau E, Ruedin P, Fromont P, Kanfer A, Sraer JD: Autoimmune neutropenia after renal transplantation. Transplantation. 1988, 46: 589-591.CrossRefPubMed Jondeau G, Bierling P, Rossert J, Rondeau E, Ruedin P, Fromont P, Kanfer A, Sraer JD: Autoimmune neutropenia after renal transplantation. Transplantation. 1988, 46: 589-591.CrossRefPubMed
38.
go back to reference Stern SC, Shah S, Costello C: Probable autoimmune neutropenia induced by fludarabine treatment for chronic lymphocytic leukaemia. Br J Haematol. 1999, 106: 836-837. 10.1046/j.1365-2141.1999.01682.x.CrossRefPubMed Stern SC, Shah S, Costello C: Probable autoimmune neutropenia induced by fludarabine treatment for chronic lymphocytic leukaemia. Br J Haematol. 1999, 106: 836-837. 10.1046/j.1365-2141.1999.01682.x.CrossRefPubMed
39.
go back to reference Sato K, Miyakawa M, Han DC, Kato S, Shibagaki Y, Tsushima T, Shizume K: Graves' disease with neutropenia and marked splenomegaly: autoimmune neutropenia due to propylthiouracil. J Endocrinol Invest. 1985, 8: 551-555.CrossRefPubMed Sato K, Miyakawa M, Han DC, Kato S, Shibagaki Y, Tsushima T, Shizume K: Graves' disease with neutropenia and marked splenomegaly: autoimmune neutropenia due to propylthiouracil. J Endocrinol Invest. 1985, 8: 551-555.CrossRefPubMed
40.
go back to reference Voog E, Morschhauser F, Solal-Céligny P: Neutropenia in patients treated with Rituximab. N Engl J Med. 2003, 348: 2691-2694. 10.1056/NEJM200306263482620.CrossRefPubMed Voog E, Morschhauser F, Solal-Céligny P: Neutropenia in patients treated with Rituximab. N Engl J Med. 2003, 348: 2691-2694. 10.1056/NEJM200306263482620.CrossRefPubMed
41.
go back to reference Besana C, Lazzarin A, Capsoni F, Caredda F, Moroni M: Phagocyte function in systemic lupus erythematosus. Lancet. 1975, 2: 918-10.1016/S0140-6736(75)92147-9.CrossRefPubMed Besana C, Lazzarin A, Capsoni F, Caredda F, Moroni M: Phagocyte function in systemic lupus erythematosus. Lancet. 1975, 2: 918-10.1016/S0140-6736(75)92147-9.CrossRefPubMed
42.
go back to reference Capsoni F, Minonzio F, Ongari AM, Soligo D, Luksch R, Mozzana R, Della Volpe A, Lambertenghi Deliliers G: Abnormal neutrophil chemotaxis after successful bone marrow transplantation. Leukemia Lymphoma. 1991, 4: 335-341.CrossRef Capsoni F, Minonzio F, Ongari AM, Soligo D, Luksch R, Mozzana R, Della Volpe A, Lambertenghi Deliliers G: Abnormal neutrophil chemotaxis after successful bone marrow transplantation. Leukemia Lymphoma. 1991, 4: 335-341.CrossRef
43.
go back to reference Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Carrabba M: Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Res Ther. 2005, 7: 250-255. 10.1186/ar1477.CrossRef Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Carrabba M: Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Arthritis Res Ther. 2005, 7: 250-255. 10.1186/ar1477.CrossRef
44.
go back to reference Meliconi R, Uguccioni M, Chieco-Bianchi F, Pitzalis C, Bowman S, Facchini A, Gasbarrini G, Panayi GS, Kingsley GH: The role of interleukin-8 and other cytokines in the pathogenesis of Felty's syndrome. Clin Exp Rheumatol. 1995, 13: 285-291.PubMed Meliconi R, Uguccioni M, Chieco-Bianchi F, Pitzalis C, Bowman S, Facchini A, Gasbarrini G, Panayi GS, Kingsley GH: The role of interleukin-8 and other cytokines in the pathogenesis of Felty's syndrome. Clin Exp Rheumatol. 1995, 13: 285-291.PubMed
45.
go back to reference Ditzel HJ, Masaki Y, Nielsen H, Farnaes L, Burton DR: Cloning and expression of a novel human antibody-antigen pair associated with Felty's syndrome. Proc Natl Acad Sci USA. 2000, 97: 9234-9239. 10.1073/pnas.97.16.9234.PubMedCentralCrossRefPubMed Ditzel HJ, Masaki Y, Nielsen H, Farnaes L, Burton DR: Cloning and expression of a novel human antibody-antigen pair associated with Felty's syndrome. Proc Natl Acad Sci USA. 2000, 97: 9234-9239. 10.1073/pnas.97.16.9234.PubMedCentralCrossRefPubMed
46.
go back to reference Fiechtner JJ, Miller DR, Starkebaum G: Reversal of neutropenia with methotrexate treatment in patients with Felty's syndrome. Correlation of response with neutrophil-reactive IgG. Arthritis Rheum. 1989, 32: 194-201.CrossRefPubMed Fiechtner JJ, Miller DR, Starkebaum G: Reversal of neutropenia with methotrexate treatment in patients with Felty's syndrome. Correlation of response with neutrophil-reactive IgG. Arthritis Rheum. 1989, 32: 194-201.CrossRefPubMed
47.
go back to reference Canvin JM, Dalal BI, Baragar F, Johnston JB: Cyclosporine for the treatment of granulocytopenia in Felty's syndrome. Am J Hematol. 1991, 36: 219-220.CrossRefPubMed Canvin JM, Dalal BI, Baragar F, Johnston JB: Cyclosporine for the treatment of granulocytopenia in Felty's syndrome. Am J Hematol. 1991, 36: 219-220.CrossRefPubMed
48.
go back to reference Talip F, Walker N, Khan W, Zimmermann B: Treatment of Felty's syndrome with leflunomide. J Rheumatol. 2001, 28: 868-870.PubMed Talip F, Walker N, Khan W, Zimmermann B: Treatment of Felty's syndrome with leflunomide. J Rheumatol. 2001, 28: 868-870.PubMed
49.
go back to reference Dillon AM, Luthra HS, Conn DL, Ferguson RH: Parenteral gold therapy in the Felty's syndrome. Experience with 20 patients. Medicine (Baltimore). 1986, 65: 107-112.CrossRef Dillon AM, Luthra HS, Conn DL, Ferguson RH: Parenteral gold therapy in the Felty's syndrome. Experience with 20 patients. Medicine (Baltimore). 1986, 65: 107-112.CrossRef
50.
go back to reference Laszlo J, Jones R, Silberman HR, Banks PM: Splenectomy for Felty's syndrome. Clinicopathological study of 27 patients. Arch Intern Med. 1978, 138: 597-602. 10.1001/archinte.138.4.597.CrossRefPubMed Laszlo J, Jones R, Silberman HR, Banks PM: Splenectomy for Felty's syndrome. Clinicopathological study of 27 patients. Arch Intern Med. 1978, 138: 597-602. 10.1001/archinte.138.4.597.CrossRefPubMed
51.
go back to reference Barnes ML, Saving KL, Vats TS: Post-splenectomy sepsis. Kans Med. 1987, 88: 119-120.PubMed Barnes ML, Saving KL, Vats TS: Post-splenectomy sepsis. Kans Med. 1987, 88: 119-120.PubMed
52.
go back to reference Hellmich B, Schnabel A, Gross WL: Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Semin Arthrit Rheum. 1999, 29: 82-89. 10.1016/S0049-0172(99)80040-7.CrossRef Hellmich B, Schnabel A, Gross WL: Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Semin Arthrit Rheum. 1999, 29: 82-89. 10.1016/S0049-0172(99)80040-7.CrossRef
53.
go back to reference Jain KK: Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J Am Acad Dermatol. 1994, 31: 213-215.CrossRefPubMed Jain KK: Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J Am Acad Dermatol. 1994, 31: 213-215.CrossRefPubMed
54.
go back to reference Bowman SJ, Bhavnani M, Geddes GC, Corrigall V, Boylston AW, Panayi GS, Lanchbury JS: Large granular lymphocyte expansions in patients with Felty's syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies. Clin Exp Immunol. 1995, 101: 18-24.PubMedCentralCrossRefPubMed Bowman SJ, Bhavnani M, Geddes GC, Corrigall V, Boylston AW, Panayi GS, Lanchbury JS: Large granular lymphocyte expansions in patients with Felty's syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies. Clin Exp Immunol. 1995, 101: 18-24.PubMedCentralCrossRefPubMed
55.
go back to reference Starkebaum G: Leukemia of large granular lymphocytes and rheumatoid arthritis. Am J Med. 2000, 108: 744-745. 10.1016/S0002-9343(00)00386-7.CrossRefPubMed Starkebaum G: Leukemia of large granular lymphocytes and rheumatoid arthritis. Am J Med. 2000, 108: 744-745. 10.1016/S0002-9343(00)00386-7.CrossRefPubMed
56.
go back to reference Coakley G, Iqbal M, Brooks D, Panayi GS, Lanchbury JS: CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes. Arthritis Rheum. 2000, 43: 834-843. 10.1002/1529-0131(200004)43:4<834::AID-ANR14>3.0.CO;2-H.CrossRefPubMed Coakley G, Iqbal M, Brooks D, Panayi GS, Lanchbury JS: CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes. Arthritis Rheum. 2000, 43: 834-843. 10.1002/1529-0131(200004)43:4<834::AID-ANR14>3.0.CO;2-H.CrossRefPubMed
57.
go back to reference Perzova R, Loughran TP: Constitutive expressionn of Fas ligand in large granular lymphocyte leukaemia. Br J Haematol. 1997, 97: 123-126. 10.1046/j.1365-2141.1997.d01-2113.x.CrossRefPubMed Perzova R, Loughran TP: Constitutive expressionn of Fas ligand in large granular lymphocyte leukaemia. Br J Haematol. 1997, 97: 123-126. 10.1046/j.1365-2141.1997.d01-2113.x.CrossRefPubMed
58.
go back to reference Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, et al: Fas ligand in human serum. Nat Med. 1996, 2: 317-322. 10.1038/nm0396-317.CrossRefPubMed Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, et al: Fas ligand in human serum. Nat Med. 1996, 2: 317-322. 10.1038/nm0396-317.CrossRefPubMed
59.
go back to reference Liu JH, Wei S, Lamy T, Epling-Burnette PK, Starkebaum G, Djeu JY, Loughran TP: Chronic neutropenia mediated by Fas ligand. Blood. 2000, 95: 3219-3222.PubMed Liu JH, Wei S, Lamy T, Epling-Burnette PK, Starkebaum G, Djeu JY, Loughran TP: Chronic neutropenia mediated by Fas ligand. Blood. 2000, 95: 3219-3222.PubMed
60.
go back to reference Hamidou MA, Sadr FB, Lamy T, Raffi F, Grolleau JY, Barrier JH: Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheumatoid arthritis. Am J Med. 2000, 108: 730-732. 10.1016/S0002-9343(00)00406-X.CrossRefPubMed Hamidou MA, Sadr FB, Lamy T, Raffi F, Grolleau JY, Barrier JH: Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheumatoid arthritis. Am J Med. 2000, 108: 730-732. 10.1016/S0002-9343(00)00406-X.CrossRefPubMed
61.
go back to reference Garipidou V, Tsatalas C, Sinacos Z: Severe neutropenia in a patient with large granular lymphocytosis: prolonged successful control with cyclosporin A. Haematologica. 1991, 76: 424-425.PubMed Garipidou V, Tsatalas C, Sinacos Z: Severe neutropenia in a patient with large granular lymphocytosis: prolonged successful control with cyclosporin A. Haematologica. 1991, 76: 424-425.PubMed
62.
go back to reference Nossent JC, Swaak AJ: Prevalence and significance of haema-tological abnormalities in patients with systemic lupus erythematosus. QJM. 1991, 80: 605-612.PubMed Nossent JC, Swaak AJ: Prevalence and significance of haema-tological abnormalities in patients with systemic lupus erythematosus. QJM. 1991, 80: 605-612.PubMed
64.
go back to reference Kurien BT, Newland J, Paczkowski C, Moore KL, Scofield RH: Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. Clin Exp Immunol. 2000, 120: 209-217. 10.1046/j.1365-2249.2000.01195.x.PubMedCentralCrossRefPubMed Kurien BT, Newland J, Paczkowski C, Moore KL, Scofield RH: Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. Clin Exp Immunol. 2000, 120: 209-217. 10.1046/j.1365-2249.2000.01195.x.PubMedCentralCrossRefPubMed
65.
go back to reference Liu H, Ozaki K, Matsuzaki Y, Abe M, Kosaka M, Saito S: Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol. 1995, 100: 480-485.PubMedCentralCrossRefPubMed Liu H, Ozaki K, Matsuzaki Y, Abe M, Kosaka M, Saito S: Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol. 1995, 100: 480-485.PubMedCentralCrossRefPubMed
66.
go back to reference Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL: Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis. 1999, 58: 309-314.PubMedCentralCrossRefPubMed Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL: Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis. 1999, 58: 309-314.PubMedCentralCrossRefPubMed
67.
go back to reference Euler HH, Harten P, Zeuner RA, Schwab UM: Recombinant human granulocyte colony stimulating factor in patients with systemic lupuis erythematosus associated neutropenia and refractory infection. J Rheumatol. 1997, 24: 2153-2157.PubMed Euler HH, Harten P, Zeuner RA, Schwab UM: Recombinant human granulocyte colony stimulating factor in patients with systemic lupuis erythematosus associated neutropenia and refractory infection. J Rheumatol. 1997, 24: 2153-2157.PubMed
Metadata
Title
Primary and secondary autoimmune neutropenia
Authors
Franco Capsoni
Piercarlo Sarzi-Puttini
Alberto Zanella
Publication date
01-09-2005
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2005
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1803

Other articles of this Issue 5/2005

Arthritis Research & Therapy 5/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.